This is a non-core endpoint: only basic statistics are computed.
Melanocytic naevi of lip
CD2_BENIGN_MELANOCYTIC_LIP_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D22
- Name in latin
- Naevus melanocyticus (cutis) labii (oris)
Melanocytic naevi of lip
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 314 | 237 | 77 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.03 |
| Median age at first event (years) | 43.83 | 42.12 | 49.11 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 291
- Matched controls
- 2908
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D22.0
ICD-10 Finland
Melanocytic naevi of lip
4503599627370496.0
323.0
264
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
18.7
46.2
73
51
2160A
ICD-9 Finland
Benign neoplasm of skin, Skin of lip[HUULEN IHON BENIGNI KASVAIN,NAEVUS PIGMENTOSUS]
+∞
28.6
27
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
25.4
24
*
115
Kela drug reimbursment
Breast cancer
+∞
24.3
23
*
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
9.4
22.6
48
60
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
11.0
22.2
43
45
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
17.9
17
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.1
17.7
50
95
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
24.8
16.7
23
10
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
8.1
16.7
38
53
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
15.8
15
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
15.8
15
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
30.5
15.4
20
7
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
14.7
14
*
H02AB02
ATC
dexamethasone; systemic
19.4
13.6
20
11
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
67.8
11.7
13
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.9
11.2
25
34
EAA10
NOMESCO Finland
Excision of lesion of lip
22.5
10.8
15
7
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
6.1
10.8
29
52
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
12.7
10.5
18
15
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
9.3
10.5
21
24
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
10.6
10.2
19
19
9733
FHL
Excision of skin change in operating room or anesthesia
12.8
10.0
17
14
L02BA01
ATC
tamoxifen; oral
103.3
9.5
10
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
9.4
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
9.4
9
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
9.4
9
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
9.4
9
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
130
Kela drug reimbursment
Malignant tumour
+∞
9.4
9
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
9.4
9
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
8.4
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.4
8
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
8.4
8
*
HA1AA
NOMESCO Finland
X-ray mammography
6.2
8.2
21
36
XQ848
NOMESCO Finland
Dermatological photography
10.4
7.6
14
14
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
5.6
7.5
21
40
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
7.3
7
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
7.3
7
*
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
+∞
7.3
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
7.3
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
XQ845
NOMESCO Finland
Dermatoscopy
20.6
7.2
10
5
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
6.7
87
489
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
12.6
6.6
11
9
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
7.7
6.5
14
19
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
71.4
6.5
7
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.5
6.4
50
221
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
6.3
6
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
6.3
6
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
+∞
6.3
6
*
L02BG03
ATC
anastrozole; oral
+∞
6.3
6
*
L02BG04
ATC
letrozole; oral
5.8
6.1
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
34
110
3.34
8.82
3.4
1.6
2.2
5.2
ug/l
0.58
29
83
55
267
2.29
6.55
3.1
2.4
23.8
24.2
%
0.08
48
231
128
911
1.68
4.70
3.7
3.5
36.8
36.4
g/l
0.32
122
845
172
1342
1.62
4.27
9.8
6.2
4.2
4.1
e9/l
0.03
149
1157
151
1154
1.59
4.00
5.5
3.6
12.3
10.6
umol/l
0.75
145
1074
54
325
1.80
3.51
2.7
2.5
2.1
3.5
e6/l
0.75
24
157
213
1819
1.53
3.08
7.6
5.2
76.3
73.8
u/l
0.35
199
1686
5
6
8.44
2.76
1.2
1.2
—
—
—
0
0
107
812
1.48
2.68
3.4
2.5
30.4
29.4
u/l
0.20
100
779
43
263
1.74
2.65
1.7
2.3
7.1
5.9
umol/l
0.37
37
218
139
1112
1.45
2.64
6.7
5.3
1.2
1.2
mmol/l
0.12
119
940
24
121
2.06
2.63
1.5
1.4
—
—
—
0
0
12
44
2.80
2.57
1.2
1.0
0.1
1.4
u/ml
—
7
15
10
33
3.10
2.55
1.1
1.2
—
—
—
0
0
222
1947
1.48
2.54
4.1
3.9
12.2
10.7
mm/h
0.70
208
1802
27
153
1.84
2.16
1.3
2.1
0.2
0.2
g/l
0.54
27
138
53
362
1.56
2.14
2.5
2.4
0.8
1.2
e6/l
0.54
23
195
119
962
1.38
2.01
2.0
1.9
98.4
96.2
pmol/l
0.17
54
479
16
77
2.14
2.00
1.3
1.2
6.9
7.5
g/l
—
10
60
16
77
2.14
2.00
1.3
1.2
—
—
—
0
0
16
77
2.14
2.00
1.3
1.2
3.4
3.9
g/l
—
10
58
78
586
1.44
2.00
2.3
2.1
2.8
3.1
mg/l
0.63
67
492
14
66
2.17
1.85
1.6
1.3
—
—
—
0
0
5
12
4.22
1.83
2.6
2.8
—
—
—
0
0
132
1099
1.35
1.81
5.0
3.7
—
—
—
0
0
277
2598
1.56
1.78
16.5
12.2
139.4
139.7
mmol/l
1.25
270
2519
121
999
1.34
1.74
5.8
5.1
1.2
1.2
mmol/l
0.25
109
898
5
13
3.89
1.72
1.2
1.7
—
—
—
0
0
19
104
1.88
1.71
1.5
1.5
196.9
232.7
miu/ml
0.21
11
55
10
42
2.43
1.69
1.5
1.5
—
—
—
0
0
15
76
2.02
1.67
1.2
1.2
3.1
3.0
g/l
—
10
59
22
128
1.77
1.65
1.2
1.2
27.0
24.9
iu/l
0.10
22
109
92
736
1.35
1.61
3.1
1.9
2.4
2.4
mmol/l
0.54
85
636
33
217
1.58
1.59
4.7
8.6
1.5
1.5
mmol/l
0.01
23
173
6
20
3.04
1.59
1.2
1.4
—
—
—
0
0
276
2603
1.50
1.54
17.2
12.3
3.9
3.9
mmol/l
0.03
270
2518
77
605
1.36
1.51
3.3
2.6
0.8
0.5
e6/l
0.68
52
446
92
748
1.33
1.43
2.0
2.2
53.4
55.8
u/l
0.39
86
695
29
194
1.55
1.32
2.6
1.8
68.5
67.9
ml/min/173m2
0.03
12
77
32
219
1.51
1.32
4.8
8.5
5.4
5.2
kpa
0.29
27
212
32
219
1.51
1.32
4.8
8.5
12.4
12.0
kpa
0.11
27
212
124
1060
1.28
1.32
2.2
2.3
80.2
77.2
nmol/l
0.73
113
951
227
2092
1.31
1.32
4.5
4.1
14.5
14.6
pmol/l
0.09
208
1932
9
44
2.08
1.28
2.2
3.1
—
—
—
0
0
239
2224
1.31
1.25
20.0
12.7
13.7
13.5
%
0.60
234
2179
18
108
1.71
1.25
1.8
1.5
—
—
—
0
0
74
597
1.31
1.21
2.6
2.9
2962.5
1224.5
ng/l
0.38
63
498
6
26
2.33
1.19
1.2
1.3
—
—
—
0
0
13
72
1.84
1.17
1.4
1.1
—
—
—
0
0
8
39
2.08
1.16
1.1
1.2
—
—
—
0
0
287
2756
1.48
1.15
11.5
8.2
25.8
24.8
u/l
0.58
279
2660
261
2470
1.34
1.12
5.6
4.8
1.9
2.3
mu/l
0.42
246
2287
273
2602
1.38
1.11
14.8
10.5
18.3
20.2
mg/l
0.61
208
1964
8
41
1.98
1.09
2.4
2.0
13.8
13.2
%
—
8
41
31
221
1.45
1.08
2.3
2.1
32.0
29.4
u/l
0.37
24
187
53
416
1.33
1.05
1.6
1.7
1398.5
1224.5
nmol/l
0.37
44
312
5
22
2.29
1.04
1.4
1.1
—
94.4
—
0
5
140
1244
1.23
1.01
3.4
2.7
103.9
87.4
ug/l
0.64
135
1159
62
503
1.29
0.98
1.3
1.3
1.3
11.7
u/ml
3.29
30
191
10
54
1.88
0.97
1.5
1.1
—
—
—
0
0
7
36
1.97
0.97
1.3
1.4
518.7
412.1
pmol/l
—
7
27
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
5
103
0.48
0.91
1.2
1.9
—
—
—
0
0
6
29
2.09
0.90
1.2
1.0
—
—
—
0
0
50
400
1.30
0.88
2.3
2.0
2.4
2.4
mmol/l
0.14
38
345
56
455
1.28
0.88
3.3
3.4
410.6
122.2
ng/l
0.76
40
313
6
30
2.02
0.87
1.2
1.0
—
—
—
0
0
6
30
2.02
0.87
1.2
1.0
—
—
—
0
0
6
30
2.02
0.87
1.2
1.0
—
—
—
0
0
6
30
2.02
0.87
1.2
1.0
—
—
—
0
0
6
30
2.02
0.87
1.2
1.2
—
—
—
0
0
6
30
2.02
0.87
1.2
1.0
—
—
—
0
0
8
45
1.80
0.85
1.1
1.8
—
—
—
0
0
18
121
1.52
0.84
3.9
8.4
0.6
0.7
%
0.38
18
121
50
408
1.27
0.77
1.9
2.1
—
—
—
0
0
18
124
1.48
0.77
3.9
8.2
1.5
1.6
%
0.06
18
124
299
2921
1.49
0.76
24.0
15.9
133.6
135.3
g/l
1.66
294
2874
18
125
1.47
0.74
1.6
2.3
9155.7
2358.3
u/l
—
5
49
22
160
1.40
0.72
3.5
2.3
5.5
4.6
kpa
0.74
22
155
89
779
1.20
0.72
3.2
2.8
—
—
—
0
0
45
366
1.27
0.72
2.0
2.0
—
—
—
0
0
5
26
1.94
0.71
1.2
1.1
—
—
—
0
0
5
26
1.94
0.71
1.2
1.1
—
—
—
0
0
5
27
1.87
0.68
1.2
1.1
—
—
—
0
0
5
27
1.87
0.68
1.2
1.1
—
—
—
0
0
5
27
1.87
0.68
1.0
1.2
—
—
—
0
0
5
27
1.87
0.68
1.2
1.1
—
—
—
0
0
13
86
1.53
0.67
1.3
1.8
—
154.3
—
0
7
75
651
1.20
0.66
1.3
1.3
0.6
2.1
u/ml
1.34
19
179
15
103
1.48
0.66
2.5
1.8
—
—
—
0
0
81
712
1.19
0.63
2.2
1.9
226.4
245.8
u/l
0.06
76
679
36
291
1.27
0.61
5.0
3.4
20.2
25.0
%
1.46
20
114
23
298
0.75
0.61
2.0
1.6
—
—
—
0
0
8
51
1.58
0.61
1.8
1.1
—
—
—
0
0
148
1368
1.15
0.61
3.8
4.3
6.8
6.6
mmol/l
0.59
129
1238
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
60
515
1.20
0.60
2.3
1.9
—
—
—
0
0
0
21
0.00
0.60
0.0
1.8
—
—
—
0
0
17
123
1.40
0.59
1.5
1.4
—
—
—
0
0
8
53
1.52
0.59
2.3
1.7
—
—
—
0
0
137
1262
1.15
0.58
3.6
3.4
0.0
0.0
estimate
0.00
26
232
0
23
0.00
0.58
0.0
1.0
—
1.1
—
0
12
187
1762
1.15
0.58
3.0
2.8
47.1
40.1
u/l
0.56
178
1658
59
509
1.20
0.56
1.2
1.3
38.1
35.4
iu/ml
0.04
18
163
8
55
1.47
0.56
2.1
1.3
—
—
—
0
0
6
40
1.51
0.52
2.5
1.3
—
—
—
0
0
6
40
1.51
0.52
1.5
1.1
—
—
—
0
0
14
189
0.73
0.50
1.9
1.7
—
—
—
0
0
56
489
1.18
0.48
1.8
1.7
496.9
29567762.8
pmol/l
0.78
48
416
65
575
1.16
0.47
1.5
1.5
21.5
21.3
nmol/l
0.06
57
489
25
201
1.26
0.46
3.2
2.5
0.7
0.7
ug/l
0.05
16
119
15
112
1.36
0.45
1.6
1.4
—
—
—
0
0
15
112
1.36
0.45
1.6
1.4
—
—
—
0
0
136
1270
1.13
0.45
5.3
4.7
0.0
0.0
estimate
0.00
27
227
79
872
0.87
0.45
2.9
3.3
26.2
77.6
ng/l
0.60
46
545
63
559
1.16
0.44
1.4
1.4
—
—
—
0
0
15
113
1.34
0.43
1.6
1.4
—
—
—
0
0
15
113
1.34
0.43
1.6
1.4
—
—
—
0
0
244
2363
1.15
0.43
6.0
5.3
39.3
39.1
mmol/mol
0.13
224
2219
5
31
1.62
0.43
8.2
1.3
—
—
—
0
0
19
149
1.29
0.43
1.8
1.3
—
—
—
0
0
27
222
1.24
0.42
2.1
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
20
159
1.28
0.41
1.2
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
27
224
1.22
0.40
2.3
1.6
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
1.0
—
0
7
249
2421
1.14
0.38
16.7
11.7
39.3
40.3
%
0.97
181
1831
5
36
1.40
0.38
1.4
1.1
—
113.9
—
0
7
136
1282
1.11
0.37
3.7
3.5
0.0
0.0
estimate
0.50
25
224
6
41
1.47
0.36
2.5
1.3
—
—
—
0
0
25
209
1.21
0.35
4.4
2.9
—
—
—
0
0
63
570
1.13
0.35
2.9
2.2
315.1
4972.4
umol/l
2.08
51
500
257
2510
1.13
0.33
4.8
4.2
5.7
5.8
mmol/l
0.81
239
2307
191
1839
1.10
0.32
3.4
3.4
—
—
—
0
0
6
47
1.28
0.32
1.2
1.4
—
—
—
0
0
37
326
1.15
0.30
1.4
1.6
1.4
1.4
%
0.05
32
295
35
309
1.15
0.28
2.3
1.7
—
—
—
0
0
15
122
1.24
0.27
1.7
1.5
—
—
—
0
0
14
113
1.25
0.27
4.8
5.3
24.8
25.1
mmol/l
0.14
14
113
17
203
0.83
0.26
1.6
1.5
—
—
—
0
0
73
681
1.09
0.24
1.7
1.7
1.3
1.4
mmol/l
0.79
61
586
6
83
0.72
0.24
1.0
1.8
—
—
—
0
0
6
83
0.72
0.24
1.5
1.3
—
—
—
0
0
5
41
1.22
0.22
1.6
1.2
—
—
—
0
0
5
41
1.22
0.22
1.6
1.2
—
—
—
0
0
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
62
581
1.08
0.19
1.5
1.6
—
—
—
0
0
62
659
0.93
0.18
3.9
3.7
0.0
0.0
estimate
0.00
24
224
245
2410
1.08
0.18
14.4
9.3
82.8
84.1
ml/min/173m2
0.42
200
1920
8
73
1.10
0.16
1.8
2.1
85.5
92.6
%
—
8
65
6
78
0.76
0.15
1.0
1.2
—
39.9
—
0
7
15
168
0.89
0.12
1.2
1.3
—
—
—
0
0
31
291
1.07
0.10
7.3
6.5
—
—
—
0
0
265
2629
1.05
0.09
5.2
4.6
2.7
2.8
mmol/l
0.65
244
2443
7
67
1.05
0.08
1.3
1.3
49.0
57.5
pmol/l
—
7
67
10
112
0.89
0.07
1.4
1.5
—
—
—
0
0
9
88
1.02
0.07
1.0
1.1
—
—
—
0
0
9
88
1.02
0.07
1.2
1.3
—
12.9
—
0
18
11
99
1.12
0.06
3.0
1.7
—
—
—
0
0
12
109
1.10
0.06
1.0
2.0
—
—
—
0
0
249
2473
1.03
0.06
4.1
3.8
1.3
1.3
mmol/l
0.44
227
2287
57
556
1.03
0.04
1.8
1.7
1.1
0.9
mg/l
0.49
38
417
13
140
0.93
0.04
1.6
1.5
—
—
—
0
0
258
2590
0.98
0.02
4.7
4.2
4.7
4.7
mmol/l
0.15
242
2424
100
992
1.01
0.01
3.9
3.4
—
—
—
0
0
28
287
0.97
0.01
5.1
4.3
32.1
32.3
%
0.03
18
183
23
229
1.00
0.00
1.1
1.2
50.0
152.9
iu/ml
—
9
97
24
237
1.01
0.00
1.7
1.8
—
—
—
0
0
24
237
1.01
0.00
1.3
2.0
391.1
378.7
nmol/l
0.11
24
216
258
2577
1.01
0.00
4.6
4.1
1.5
1.5
mmol/l
0.06
238
2399
0
9
0.00
0.00
0.0
1.3
—
205.3
—
0
9
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
1.2
—
0
7
6
67
0.89
0.00
2.2
1.7
—
—
—
0
0
6
66
0.91
0.00
1.5
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
7
69
1.01
0.00
2.3
1.8
—
—
—
0
0
9
89
1.01
0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MELANOCYTIC_LIP_EXALLC – Melanocytic naevi of lip
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).